Overview
- 2 inspections across 2 sites are on record.
- 6 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-11-04.
At a glance
Inspections
2
Sites
2
Observations
6
Career since
Sep 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Glaxo Operations UK Ltd | 4 Nov 2022 | Human Drugs | |
| Vertex Pharmaceuticals Incorporated | 7 Sep 2017 | Human Drugs | View 483 → |
Sites inspected
Glaxo Operations UK LtdWare, United Kingdom1 insp.
Vertex Pharmaceuticals IncorporatedBoston, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Feiyan Jin1 shared
Colleen F Hoyt1 shared
Ileana Barreto-Pettit1 shared
Yong Hu1 shared
Christina A Capacci-Daniel1 shared
Sean R Marcsisin1 shared
Full investigator report
Get the verbatim findings behind Sharmista Chatterjee's 6 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site